NH
Therapeutic Areas
Stylus Medicine Pipeline
| Drug | Indication | Phase |
|---|---|---|
| In vivo CAR-T Therapy | Oncology (unspecified) | Pre-clinical |
Leadership Team at Stylus Medicine
EN
Emile Nuwaysir, Ph.D.
Chairman & Chief Executive Officer
JF
Jason Fontenot, Ph.D.
Chief Scientific Officer
CR
Celeste Richardson, Ph.D.
SVP, Immunology
HC
Hak Chang, Ph.D., J.D.
Vice President, Intellectual Property
SC
Srinivas Chollangi, Ph.D.
Executive Director, CMC Tech Ops